thereapeutics - bone, cartilage, soft tissueAnika Therapeutics, Inc. develops manufactures and commercializes therapeutic products and devices intended to promote the repair, protection and healing of bone, cartilage and soft tissue. These products are based on hyaluronic acid, a naturally occurring, biocompatible polymer found throughout the body. In addition to ORTHOVISC (not for sale in U.S), Anika markets HYVISC(R) in the U.S. for the treatment of equine osteoarthritis through Boehringer Ingelheim Vetmedica, Inc. and manufactures AMVISC(R) and AMVISC(R) Plus, highly viscous HA products used as viscoelastic supplements during ophthalmic surgery, for worldwide marketing and distribution by Bausch & Lomb Surgical. Therapies currently under development include INCERT(R), a family of HA products designed to prevent post-surgical adhesions. Anika is also collaborating with Orquest, Inc. to manufacture Ossigel(R), an injectable formulation of basic fibroblast growth factor combined with HA designed to accelerate the healing of bone fractures.